Hanbing Ning

687 total citations
25 papers, 499 citations indexed

About

Hanbing Ning is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Hanbing Ning has authored 25 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Hanbing Ning's work include Cancer-related molecular mechanisms research (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and MicroRNA in disease regulation (3 papers). Hanbing Ning is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and MicroRNA in disease regulation (3 papers). Hanbing Ning collaborates with scholars based in China and United States. Hanbing Ning's co-authors include Tingting Li, Shuai Lv, Denis Firsanov, Andrei Seluanov, Vera Gorbunova, Masaki Takasugi, Gregory Tombline, Yingxia Li, Julia Ablaeva and Wentao Ma and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Hanbing Ning

25 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanbing Ning China 14 247 136 85 66 65 25 499
Jun Tan China 12 332 1.3× 201 1.5× 78 0.9× 35 0.5× 39 0.6× 33 800
Shogo Kasuda Japan 12 202 0.8× 72 0.5× 42 0.5× 39 0.6× 86 1.3× 54 582
Xingchun Zhou China 15 323 1.3× 113 0.8× 73 0.9× 28 0.4× 37 0.6× 22 649
Laura D’Ignazio United Kingdom 8 273 1.1× 283 2.1× 56 0.7× 61 0.9× 39 0.6× 10 641
Sophie Sarret Switzerland 3 305 1.2× 71 0.5× 84 1.0× 52 0.8× 26 0.4× 3 562
Rong‐Hua Yin China 14 360 1.5× 64 0.5× 71 0.8× 41 0.6× 66 1.0× 36 571
Ruyi Xu China 9 330 1.3× 137 1.0× 79 0.9× 39 0.6× 52 0.8× 31 644
Huiting Su China 12 195 0.8× 58 0.4× 95 1.1× 43 0.7× 89 1.4× 24 589
Tianhua Lei United States 8 323 1.3× 146 1.1× 69 0.8× 27 0.4× 42 0.6× 14 606

Countries citing papers authored by Hanbing Ning

Since Specialization
Citations

This map shows the geographic impact of Hanbing Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanbing Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanbing Ning more than expected).

Fields of papers citing papers by Hanbing Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanbing Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanbing Ning. The network helps show where Hanbing Ning may publish in the future.

Co-authorship network of co-authors of Hanbing Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Hanbing Ning. A scholar is included among the top collaborators of Hanbing Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanbing Ning. Hanbing Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jingyun, et al.. (2024). POU6F1 promotes ferroptosis by increasing lncRNA-CASC2 transcription to regulate SOCS2/SLC7A11 signaling in gastric cancer. Cell Biology and Toxicology. 40(1). 3–3. 13 indexed citations
2.
Xie, Jianxin, Mingbang Wang, Hanbing Ning, et al.. (2023). Global burden of type 2 diabetes in adolescents and young adults, 19902019: systematic analysis of the Global Burden of Disease Study 2019. Yearbook of pediatric endocrinology. 34 indexed citations
3.
Lu, Xiaoxiao, Jianhui Zhang, Wentao Ma, et al.. (2022). Pneumocystis Jirovecii Pneumonia Diagnosis via Metagenomic Next-Generation Sequencing. Frontiers in Medicine. 9. 812005–812005. 17 indexed citations
4.
Li, Lu, Hui Liu, Shuang Liu, et al.. (2021). A novel compound heterozygous mutation in ABCB4 gene in a pedigree with progressive familial intrahepatic cholestasis 3: a case report. Annals of Translational Medicine. 9(5). 426–426. 6 indexed citations
6.
Lv, Shuai, et al.. (2021). CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis. Scientific Reports. 11(1). 386–386. 23 indexed citations
8.
Li, Xin, et al.. (2021). MicroRNA‐340‐5p increases telomere length by targeting telomere protein POT1 to improve Alzheimer's disease in mice. Cell Biology International. 45(6). 1306–1315. 11 indexed citations
9.
Takasugi, Masaki, Denis Firsanov, Gregory Tombline, et al.. (2020). Naked mole-rat very-high-molecular-mass hyaluronan exhibits superior cytoprotective properties. Nature Communications. 11(1). 2376–2376. 79 indexed citations
10.
Ning, Hanbing, Wenquan Lu, Jingyun Wang, et al.. (2020). Discovery of oxyepiberberine as a novel tubulin polymerization inhibitor and an anti-colon cancer agent against LS-1034 cells. Investigational New Drugs. 39(2). 386–393. 7 indexed citations
11.
Lv, Shuai, et al.. (2020). Mesenchymal epithelial transition factor regulates tumor necrosis factor-related apoptotic induction ligand resistance in hepatocellular carcinoma cells through down-regulation of cyclin B1. The International Journal of Biochemistry & Cell Biology. 128. 105844–105844. 3 indexed citations
13.
Lu, Wenquan, Zhen Ni, Shuqin Jiang, et al.. (2020). DKK1 is epigenetically downregulated by promoter methylation and inhibits bile acid-induced gastric intestinal metaplasia. Biochemical and Biophysical Research Communications. 523(3). 780–786. 12 indexed citations
14.
Lu, Wenquan, Zhen Ni, Shuqin Jiang, et al.. (2020). Resveratrol inhibits bile acid‐induced gastric intestinal metaplasia via the PI3K/AKT/p‐FoxO4 signalling pathway. Phytotherapy Research. 35(3). 1495–1507. 32 indexed citations
15.
Li, Yingxia, et al.. (2018). Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a. Biomedicine & Pharmacotherapy. 108. 1775–1782. 47 indexed citations
16.
Ning, Hanbing, et al.. (2016). Intravenous administration of adipose tissue-derived stem cells enhances nerve healing and promotes BDNF expression via the TrkB signaling in a rat stroke model. Neuropsychiatric Disease and Treatment. 12. 1287–1287. 17 indexed citations
17.
Yang, Lijun, et al.. (2015). Rap1 is indispensable for TRF2 function in etoposide-induced DNA damage response in gastric cancer cell line. Oncogenesis. 4(3). e144–e144. 15 indexed citations
18.
Zhao, Lei, Yiting Wang, Hanbing Ning, et al.. (2007). Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. International Journal of Clinical Practice. 62(7). 1056–1062. 58 indexed citations
19.
Ning, Hanbing & Tingting Li. (2006). TRF2 promotes multidrug resistance in gastric cancer cells. Cancer Biology & Therapy. 5(8). 950–956. 35 indexed citations
20.
Ning, Hanbing, Jichang Li, Zhiguo Liu, & Daiming Fan. (2006). DNA damage increases telomerase activity and mRNA expression of telomeric repeat binding factor 2 in gastric cancer cells. World Chinese Journal of Digestology. 14(10). 942–942. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026